SEC Filings for Ligand Pharmaceuticals Incorporated (LGND)

$ 102.24   0.67 (+0.66%) Volume: 311.36k 4:00 PM EDT 1-Jun-2020
Filing Type:
Form TypeForm DescriptionPagesDateView
10-QGeneral form for quarterly reports under Section 13 or 15(d)505/14/1999
SC 13G/A[Amend] Statement of acquisition of beneficial ownership by individuals102/09/1999
S-8Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans512/30/1998
8-A12G/A[Amend] Registration of securities [Section 12(g)]212/24/1998
10-K/A[Amend] Annual report [Section 13 and 15(d), not S-K Item 405]311/25/1998
10-QGeneral form for quarterly reports under Section 13 or 15(d)911/16/1998
8-A12G/A[Amend] Registration of securities [Section 12(g)]211/10/1998
SC 13D/A[Amend] General statement of acquisition of beneficial ownership210/28/1998
8-K/A[Amend]Current report pursuant to Section 13 or 15(d)309/25/1998
8-KCurrent report pursuant to Section 13 or 15(d)308/25/1998
SC 13D/A[Amend] General statement of acquisition of beneficial ownership108/21/1998
10-QGeneral form for quarterly reports under Section 13 or 15(d)208/14/1998
S-4Registration statement under Securities Act of 19331607/09/1998
SC 13D/A[Amend] General statement of acquisition of beneficial ownership305/22/1998
3Initial statement of beneficial ownership of securities105/21/1998
101102103104105106107108109110111112113114115